Clinical Trial Update: Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany [Phase 4]

View source ↗

Summary

Phase 4 trial in Germany comparing atomoxetine with placebo in children and adolescents with ADHD and comorbid Oppositional Defiant Disorder; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Oppositional Defiant Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder | Phase 4 | Status: COMPLETED | Results posted: 2010-02-12